FDA Investigator Matthew A Spataro

Matthew A Spataro has inspections in 3 countries as of 23 Oct 2023. Matthew A Spataro has collaborated with a combinined 4140 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:

Last Inspection Date:

23 Oct 2023

Investigator Role:

FDA Investigator

Redica ID:

100000331

Country:

United States of America, Germany

Co-Investigator(s):

Alberto A Viciedo, Alice S Tsao, Allen Lou, Amber D Brodas, Anissa M Vargas, Ann M Stewart, Ann Marie Montemurro, Anna M Alexander, Annemarie B Randow, Annemarie Bodnar, Antonina Aydanian, Arduino Frankovic, Arsen Karapetyan, Ayorinde O Babalola, Aziz A Mamur, Barbara J Maulfair, Barbara J Wilimczyk, Barbara Jwilimczyk Macri, Barbara M Frazier, Benton M Ketron, Bijoy Panicker, Byungja E Marciante, Charanjeet Jassal, Charisse K Green, Charles J Chacko, Charles Jewell, Cheryl A Grandinetti, Christina N Maurino, Concepcion Cruz, Jr, Cory Greene, Cynthia Jim, CSO, D Jenny Argiropoulos, Daniel J Grabicki, David H Smith, David R Delucia, Deborah B Nixon, Demetria J Arpropractor, Demitria J Argiiropoulos, Demitria J Argiropolous, Demitria J Argiropoulos, Demitria J Xiradakis, Denise M Visco, Investigator, Dennis E Guilfoyle, PhD, Diane L Raccasi, Dinesh Kumar, Donald G Gordon, Douglas C Kovacs, Dr. Barbara D Paul, PhD, Dr. Robert C Horan, MD, Emmanuel J Ramos, Emmanuel Jramos Maldonado, Eric Rothschild, Erin D Mccaffery, Evan Tong, Felix Maldonado, Frank Verni, Frank Wackes, Freyja V Lynn, Gam S Zamil, Gary T Greco, George Pyramides, Gianine E Tompkins, Gifford Whitehurst, Jr, Gloria E Parra, Gray, Gregson A Joseph, Gregson Joseph, Guerlain Ulysse, Haitao Li, Helen B Ricalde, Helen Verdel, Iram R Hassan, PhD, Irina Gaberman, Jacqueline Mdiaz Albertini, Jacqueline S Warner, Jagdish R Amin, James A Liubicich, James C Maclaughlin, James M Mason, Jane Chen, Janet A Rajan, Jason Kwong, Jawaid Hamid, Jean M Kelahan, Jennifer L Bridgewater, Joan A Loreng, Jogy George, John A Podsadowski, John E Aghadia, Jose Acruz Gonzalez, Jose M Cayuela, Joseph Milcetic, Joy P Matthias, Joy R Kelna, Joy Rkozlowski Klena, Julie D Bringger, Junho Pak, Karen E D'orazio, Karen L Kosar, Karishma G Gopaul, Kassa Ayalew, MD, Keith M Reilly, Kelli F Dobilas, Kellie Leveille, Kenneth H Williams, Kerun Hardeo, Kevin A Gonzalez, Kristina L Conroy, Kristy A Zielny, Kumar G Janoria, Kwong P Lee, L Gnnmassimia Massimilla, PharmD, Larry K Austin, Lata C Mathew, PhD, Lawrence W Farina, Leena Thomas, Li Li, Liatte Kreuger, PharmD, Lirissia Mccoy, Lisa Harlan, Lori P Peters, LTJG Matthew R Palo, Manhar R Patel, Maotang Xhou, Maotang Zhou, PhD, Margaret E Sarles, Margaret M Annes, Maria Joselopez Barragan, PhD, Marjorie A Shapiro, PhD, Marsha W Major, Marshalette O Edwards, Martha T Olone, Mary Davis Lopez, Mate Tolnay, Matthew A Spalazo, Matthew A Sparato, Matthew Sparato, Mayar M Mussa, Melba Trivera Clavell, Melissa T Roy, Meyer J Slobotsky, Michael A Charles, Michael Dominick, Michael Levin, Michael Levine, Michael R Dominick, Michael R Klapal, Michael Serrano, Mihaly S Ligmond, Milan S Blake, Milan S Mcgorty, Mindy M Chou, Mra Mcculloughj, Nancy A Saxenian Emmons, Nancy F Scheraga, Nancy L Rolli, Nancy Roll, Nancy T Waites, Neil J Bonzagni, PhD MPH, Niketa Patel, Nina Yang, Omotunde O Osunsanmi, Parul M Patel, Paul E Stein, Paul L Bellamy, Paul Mouris, Paula A Trost, Perry T Nichols, Peter Abel, Peter R Lenahan, Philip F Istafanos, DMV, MS, Prabhu P Raju, Raymond M Lam, Regina T Brown, Richard W Thornton, Richard W Thorntton, Robert C Steyert, Robert G Ruff, Robert Jennings, Robert W Jennings, Robin P Mathew, Rochelle K Kimmel, Rodney T Allnutt, S Thomas, Samuel T Walker, Sandra A Hughes, Sandra D Thompson, Sarah A Meehan, Sarah B Tanksley, Satheesh Thomas, Sayyem H Akbar, Scott E Norris, Shari L Kahn, Sidney B Priesmeyer, Simone E Pitts, Sixto M Mercado Rios, Sony Mathews, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, State Agency, Stella Yuen, Stephanie T Durso, Stephen D Brown, Stephen J Mottola, Steven M Weinman, Susan F Laska, MS, Susan M Jackson, Syeda N Mahazabin, Tamil Arasu, PhD, Tania E Vizcaino, Tara G Bizjak, Tara K Carmody, Tara R Gooen, Ted L Anderson, Tej Poonai, Thomas P Hansen, Tina S Roecklein, Tonia F Bernard, Tyanna N Hadley, Tynna N Hadley, Uduak M Inokon, Unnee Ranjan, Valentino Fiorella, Vanessa M Williams, Vivin George, Wayne E Seifert, Willy A Orantes, Winston R Alejo, Xiaoping Guan, Xikui Chen (nmi), PhD, Yvesna C Blaise, Yvins Dezan, Zakaria I Ganiyu, Zhijin Chen, Zhongren Wu

Matthew A Spataro's Documents

Publish Date	Document Type	Title
April, 2001	FDA 483	Strides Pharma, Inc - Form 483, 2001-04-10
November, 2002	EIR	Barr Laboratories Inc. - EIR, 2002-11-12
January, 2001	FDA 483 Response	Merck, Inc. - Form 483R, 2001-02-16
September, 2002	FDA 483	Geritrex, LLC - Form 483, 2002-09-18
February, 2000	FDA 483 Response	Merck, Inc. - Form 483R, 2000-03-20
May, 2003	FDA 483 Response	Barr Laboratories Inc. - Form 483R, 2003-08-05
April, 2000	FDA 483	Barr Laboratories, Inc. - Form 483, 2000-04-17
June, 2004	EIR	Strides Pharma, Inc - EIR, 2004-06-22
September, 2001	EIR	Taro Pharmaceuticals U.S.A., Inc. - EIR, 2001-09-17
January, 2001	EIR	Merck, Inc. - EIR, 2001-01-19
May, 2000	FDA 483	Actavis Totowa LLC - Form 483, 2000-05-23
July, 2004	FDA 483 Response	Pfizer Inc. - Form 483R, 2004-08-27
June, 2004	FDA 483	Strides Pharma, Inc - Form 483, 2004-06-22
February, 2003	FDA 483	Novartis Pharmaceuticals Corp. - Form 483, 2003-02-21
May, 2000	FDA 483 Response	Actavis Totowa LLC - Form 483R, 2000-07-02
July, 2002	EIR	Auxilium Pharmaceuticals, LLC - EIR, 2002-07-01
August, 2000	EIR	Barr Laboratories, Inc. - EIR, 2000-08-28
February, 2001	EIR	Maypro Industries, Inc. - EIR, 2001-02-13
April, 2001	EIR	Strides Pharma, Inc - EIR, 2001-04-10
April, 2000	EIR	Barr Laboratories, Inc. - EIR, 2000-04-17
November, 2002	FDA 483 Response	Barr Laboratories Inc. - Form 483R, 2003-02-26
January, 2002	EIR	Wyeth Pharmaceutical Division of Wyeth Holdings LLC - EIR, 2002-01-24
February, 2003	EIR	Novartis Pharmaceuticals Corp. - EIR, 2003-02-21
January, 2001	FDA 483	Merck & Co., Inc. - Form 483, 2001-01-19
March, 2001	FDA 483	Pfizer, Inc. - Form 483, 2001-03-02
April, 2005	FDA 483	Watson Laboratories, Inc. - Form 483, 2005-04-28
April, 2001	FDA 483 Response	Strides Pharma, Inc - Form 483R, 2001-04-30
August, 2000	FDA 483 Response	Halo Pharmaceutical Inc - Form 483R, 2000-08-29
February, 2000	FDA 483	Merck, Inc. - Form 483, 2000-02-25
December, 2002	FDA 483	Sanofi-Aventis U.S. LLC - Form 483, 2002-12-19
August, 2000	FDA 483	Barr Laboratories, Inc. - Form 483, 2000-08-28
August, 2001	EIR	Pfizer Inc. - EIR, 2001-08-07
May, 2003	FDA 483	Barr Laboratories Inc. - Form 483, 2003-05-09
February, 2000	FDA 483	Merck, Inc. - Form 483, 2000-02-25
May, 2013	EIR	Excella GmbH & Co. KG - EIR, 2013-05-17
February, 2002	FDA 483	AMA Laboratories, Inc. - Form 483, 2002-02-26
January, 2002	FDA 483 Response	Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Form 483R, 2002-02-25
January, 2002	FDA 483	Wyeth Pharmaceutical Division of Wyeth Holdings LLC - Form 483, 2002-01-24
July, 2004	EIR	Pfizer Inc. - EIR, 2004-07-29
September, 2003	FDA 483	Silarx Pharmaceutical, Inc. - Form 483, 2003-09-17
February, 2003	FDA 483 Response	Novartis Pharmaceuticals Corp. - Form 483R, 2003-03-07
October, 2000	FDA 483	Ingenus Pharmaceuticals NJ, LLC - Form 483, 2000-10-17
May, 2000	EIR	Actavis Totowa LLC - EIR, 2000-05-23
March, 2004	EIR	Auxilium Pharmaceuticals, LLC - EIR, 2004-03-08
July, 2004	FDA 483	Pfizer Inc. - Form 483, 2004-07-29
June, 2004	FDA 483 Response	Strides Pharma, Inc - Form 483R, 2004-07-16
November, 2002	FDA 483	Barr Laboratories Inc. - Form 483, 2002-11-12
March, 2004	FDA 483	Auxilium Pharmaceuticals, LLC - Form 483, 2004-03-08
August, 2000	FDA 483	Halo Pharmaceutical Inc - Form 483, 2000-08-04
October, 2001	EIR	Perrigo New York, Inc. - EIR, 2001-10-26
August, 2001	FDA 483	Pfizer Inc. - Form 483, 2001-08-07
April, 2013	EIR	ScieGen Pharmaceuticals, INC. - EIR, 2013-04-02
May, 2004	FDA 483	Novartis Pharmaceuticals Corp. - Form 483, 2004-05-21
May, 2003	EIR	Barr Laboratories Inc. - EIR, 2003-05-09
February, 2000	EIR	Merck, Inc. - EIR, 2000-02-25
April, 2005	EIR	Watson Laboratories, Inc. - EIR, 2005-04-28
August, 2000	EIR	Halo Pharmaceutical Inc - EIR, 2000-08-04
September, 2013	EIR	ScieGen Pharmaceuticals, INC. - EIR, 2013-09-18
July, 2003	FDA 483	Perrigo New York, Inc. - Form 483, 2003-07-10
July, 2002	EIR	SML Acquisition, LLC (aka San-mar Laboratories, Inc) - EIR, 2002-07-11
January, 2001	FDA 483	Merck, Inc. - Form 483, 2001-01-19
December, 2013	EIR	Epic Pharma, LLC - EIR, 2013-12-23
April, 2000	FDA 483 Response	Barr Laboratories, Inc. - Form 483R, 2000-06-28
December, 2004	EIR	Wyeth Pharmaceutical Division of Wyeth Holdings LLC - EIR, 2004-12-10
October, 2004	EIR	Strides Pharma, Inc - EIR, 2004-10-05

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more